Mo Jun, Shen Huimin, Yang Tian, Xu Dan, Xing Ruxin, Wang Bo, Chen Yili
Department of Neurosurgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
Department of Neurosurgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
World Neurosurg. 2025 Jan;193:176-183. doi: 10.1016/j.wneu.2024.10.101. Epub 2024 Nov 21.
We describe a 2-stage strategy utilizing the endoport-assisted endoscopic technique for the evacuation of severe intraventricular hemorrhage (IVH) with a cast third ventricle, and discuss potential pitfalls in the implementation of this method in clinical practice.
Patients with severe IVH (Graeb score >6) and a cast third ventricle who presented to our center from 2021 to 2023 were treated with a 2-stage surgical strategy utilizing the endoport-assisted endoscopic technique.
A total of 9 patients with mean age of 55 years were included in the study. The preoperative mean Graeb score was 9, and postoperative mean Graeb score was 3, with a 72% evacuation rate for the entire ventricles. The median duration for external ventricular drainage was observed to be 6 days. In terms of 90-day modified Rankin Scale (mRS) scores, a favorable outcome (mRS 1-3) was demonstrated in 78% of the patients, while the remaining 22% presented with a poor outcome (mRS 4-6). There were no complications related to the surgery itself in any of the reported cases.
The endoport-assisted 2-stage endoscopic technique marks a significant advancement in treating severe IVH with a cast third ventricle. By combining dry and underwater approaches, it provides an innovative solution for effectively and safely clearing hematomas in both lateral and third ventricles. This technique addresses the crucial need for early cerebrospinal fluid circulation restoration, potentially improving outcomes for patients with these complex cases.
我们描述一种两阶段策略,利用经皮脑室引流辅助内镜技术清除伴有铸型第三脑室的严重脑室内出血(IVH),并讨论在临床实践中实施该方法时可能存在的陷阱。
对2021年至2023年就诊于我们中心的伴有铸型第三脑室的严重IVH(Graeb评分>6)患者采用经皮脑室引流辅助内镜技术的两阶段手术策略进行治疗。
本研究共纳入9例平均年龄为55岁的患者。术前平均Graeb评分为9分,术后平均Graeb评分为3分,全脑室血肿清除率为72%。观察到外部脑室引流的中位持续时间为6天。在90天改良Rankin量表(mRS)评分方面,78%的患者预后良好(mRS 1 - 3),其余22%的患者预后较差(mRS 4 - 6)。在所有报告的病例中均未出现与手术本身相关的并发症。
经皮脑室引流辅助两阶段内镜技术是治疗伴有铸型第三脑室的严重IVH的一项重大进展。通过结合干式和水下操作方法,它为有效、安全地清除侧脑室和第三脑室血肿提供了一种创新解决方案。该技术满足了早期恢复脑脊液循环的关键需求,可能改善这些复杂病例患者的预后。